Evaluation of the Safety and Immunogenicity of SII Vaccine Constructs Based on the SARS-CoV-2 (COVID-19) Variant in Adults

NCT05029856 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study never started

Conditions

Covid19

Interventions

BIOLOGICAL: SII B.1.351
BIOLOGICAL: SII B.1.351
BIOLOGICAL: SII Bivalent
BIOLOGICAL: SII Bivalent
BIOLOGICAL: SII B.1.617.2

Sponsor

Novavax